Evidence map›Paper›PMID 40057242›Full record

ArticleJournal of substance use and addiction treatment2025

Implementing a pre-exposure prophylaxis (PrEP) promotion intervention among persons who inject drugs: Perspectives from community and research implementation partners.

Charles A Warnock, Colleen Mistler, Adam Viera, Dini Harsono, June Weiss, Daniel Davidson, Genie L Bailey, Marianne Buchelli, Kathy Eggert, River Rose and 6 more

Abstract read
In one paragraph

Article in Journal of substance use and addiction treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Charles A WarnockDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA. Electronic address: charles.warnock@yale.edu.
Colleen MistlerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Adam VieraCollaborative Center to Advance Health Services, University of Missouri, Kansas City, MO, USA.
Dini HarsonoCenter for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
June WeissDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Daniel DavidsonCenter for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA.
Genie L BaileyDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA; Stanley Street Treatment and Resources (STARR) Inc., Fall River, MA, USA.
Marianne BuchelliConnecticut Department of Public Health, Hartford, CT, USA.
Kathy EggertAPT Foundation, Inc., New Haven, CT, USA.
River RoseConnecticut Harm Reduction Alliance, Hartford, CT, USA.
Joanne MontgomeryLiberation Programs Inc., Stamford, CT, USA.
Portia RobinsonRecovery Network of Programs, Inc., Bridgeport, CT, USA.
Oscar F Rojas PerezDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Ellie PickeringYale School of Nursing, New Haven, CT, USA.
Carla J RashUniversity of Connecticut Health School of Medicine, Farmington, CT, USA.
E Jennifer EdelmanDepartment of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.

Funding

Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
INTERDISCIPLINARY HIV PREVENTION TRAINING PROGRAMT32MH020031 · NIMH · YALE UNIVERSITY · PI Trace S Kershaw · 1999 to 2026
$12.1M
Research Training Program in Substance Use PreventionT32DA019426 · NIDA · YALE UNIVERSITY · PI TAMI P SULLIVAN · 2005 to 2026
$7.5M
Promoting HIV risk reduction among people who inject drugs: A stepped care approach using contingency management with PrEP navigationR01DA051871 · NIDA · YALE UNIVERSITY · PI EDELMAN, E. JENNIFER · 2020 to 2025
$5.4M
NIDA NIH HHS R01 DA051871NIDA NIH HHS T32 DA019426NIMH NIH HHS P30 MH062294NIMH NIH HHS T32 MH020031
6 · The paper itself

Abstract

backgroundClinical guidelines recommend pre-exposure prophylaxis (PrEP) to prevent HIV among persons who inject drugs (PWID), yet few are reached by this evidence-based intervention. To address this challenge, we are conducting a clinical trial to evaluate the impact of contingency management (CM) with stepped care to PrEP adherence and support services (PASS) among PWID. We sought to elicit perspectives from community- and research-based implementation partners on barriers and facilitators to implementing this intervention package as well as describe perspectives around evidence-based research practices in general.

methodsIn October 2023, we conducted three focus groups with community-based site staff (n = 8), site leadership (n = 6), and research coordinators (n = 6) involved in delivering and implementing the intervention. The Promoting Action on Research Implementation in Health Service (PARIHS) implementation science framework construct (evidence, context, and facilitation opportunities) informed qualitative data collection and analysis.

resultsRegarding evidence, focus group participants had a mix of previous experience or backgrounds in behavioral and interventional research with pre-existing research experience and embedded research infrastructure described as implementation facilitators. Participants described initially mixed views towards CM but became more positive as participants engaged in trial implementation. Regarding context within the community-based setting, focus group participants acknowledged challenges in promoting PrEP among PWID given competing social needs as well as individual and service priorities. Participants described turnover and burnout among staff delivering the intervention in addition to providing regular day-to-day services as major barriers to implementation. Regarding future intervention facilitation opportunities, participants suggested integrating interventional activities into off-site services like outreach as well as increasing the number of CM sessions. To facilitate site engagement and localized practice improvement, site leadership emphasized the need for consistent research team presence and detailed correspondence of results at the conclusion of research.

conclusionFocus group participants identified barriers and facilitators to implementing and sustaining CM-based PrEP promotion interventions within community-based settings. Efforts should be made to anticipate and address staff capacity and turnover when implementing HIV prevention interventions within community settings. Additionally, integrating CM-based PrEP promotion programs into off-site services and operations to reach PWID could be an opportunity to increase reach.

Indexed as

Health PromotionHIV InfectionsPre-Exposure ProphylaxisSubstance Abuse, IntravenousAdultFemaleFocus GroupsHumansImplementation ScienceMaleContingency managementHIVImplementationInjection drug usePre-exposure prophylaxis

Identifiers

PMID40057242
PMCPMC12009193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.